Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
A new era in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): clinical breakthroughs and challenges
Frontiers in pharmacology, 2026;17:1815576
Glucagon-like peptide-1 receptor agonists and tirzepatide are associated with reduced mortality, cardiovascular, and psychiatric risks in patients with hidradenitis suppurativa and type 2 diabetes and/or obesity: a retrospective cohort study
Frontiers in medicine, 2026;13:1909537
Neuropsychiatric Outcomes Associated with GLP-1 Receptor Agonists in Adults with Overweight or Obesity: A Systematic Review
Brain sciences, 2026;16(9)
Potential Role of the Triple Receptor Agonist Retatrutide in Antipsychotic-Associated Metabolic Dysfunction Among Clozapine- and Olanzapine-Treated Schizophrenia Spectrum Disorders: A Narrative Review and Theoretical Framework
Biomedicines, 2026;14(9)
Comparison of cardiometabolic benefits and tolerability in patients on sustained low doses of semaglutide or tirzepatide
Biology methods & protocols, 2026;11(1):bpag048
Intrathecal semaglutide attenuates burn injury-induced pain in mice through a spinal GLP-1R-linked enkephalin/δ-opioid receptor pathway
Neuropharmacology, 2026;:111163
Intranasal delivery of Semaglutide using a thermoresponsive PNPHO nanocarrier: formulation development, characterization and biological evaluation
International journal of pharmaceutics, 2026;:127363
Unilateral Graves’ Disease Developing During Treatment With Tirzepatide in a Patient With Diabetes: A Case Report
Case reports in endocrinology, 2026;2026:9628050
Beyond Weight Loss: Thromboinflammation as a Candidate Mechanism for the Cardiovascular Benefit of GLP-1 Receptor Agonists
Cells, 2026;15(17)
Efficient Expression of Small Molecule Bioactive Peptides in Bacillus licheniformis
Applied biochemistry and biotechnology, 2026
OAF Blocks SIAH1-Mediated Degradation of SCPX, a Therapeutic Strategy for MASLD
Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026;:e77451
Effects of subcutaneous semaglutide on weight loss and inflammatory markers in adults with overweight or obesity without diabetes: a systematic review and meta-analysis
International journal of obesity (2005), 2026
Drug failure in diabetic kidney disease: translational barriers, target validation and trial de-risking strategies
Biochemical pharmacology, 2026;:118405
Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial
Journal of diabetes and its complications, 2026;40(10):109397
Comparative effectiveness of GLP-1 receptor agonists versus mineralocorticoid receptor antagonists as fourth-line pharmacological therapy in patients with resistant hypertension and overweight or obesity: a retrospective multicenter cohort study in the USA
EClinicalMedicine, 2026;99:104176
A Systematic Review of the Mechanisms and Therapeutic Applications of GHK-Cu (Glycyl-L-Histidyl-L-Lysine-Copper Complex) in Topical Microneedle Delivery: A Case for Expanded Clinical Trials
Archives of internal medicine research, 2026;9(3):269-293
Semaglutide in Japanese participants with metabolic dysfunction-associated steatohepatitis: a subgroup analysis of the ESSENCE trial
Journal of gastroenterology, 2026
Dramatic Improvement of Treatment-Refractory Prurigo Nodularis Following Initiation of Semaglutide: A Case Report
Clinical, cosmetic and investigational dermatology, 2026;19:606727
Oral small-molecule GLP-1 receptor agonists: a new Frontier in cardiometabolic medicine
Frontiers in pharmacology, 2026;17:1933018
Case Report: Tirzepatide improves glycemic control in Rabson-Mendenhall syndrome
Frontiers in endocrinology, 2026;17:1945251